<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Volume Spike Investor &#187; osteoporosis</title>
	<atom:link href="http://vsinvestor.com/tag/osteoporosis/feed" rel="self" type="application/rss+xml" />
	<link>http://vsinvestor.com</link>
	<description>Investing in stocks based on short term spikes in volume</description>
	<lastBuildDate>Sat, 05 Nov 2011 14:20:15 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2</generator>
		<item>
		<title>52-Week High/Volume Surge: Amgen (AMGN)</title>
		<link>http://vsinvestor.com/2008/07/52-week-highvolume-surge-amgen-amgn.html</link>
		<comments>http://vsinvestor.com/2008/07/52-week-highvolume-surge-amgen-amgn.html#comments</comments>
		<pubDate>Mon, 28 Jul 2008 12:59:51 +0000</pubDate>
		<dc:creator>247admin</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[pre-market]]></category>
		<category><![CDATA[Amgen]]></category>
		<category><![CDATA[AMGN]]></category>
		<category><![CDATA[osteoporosis]]></category>

		<guid isPermaLink="false">http://www.vsinvestor.com/?p=212</guid>
		<description><![CDATA[The most active stock in pre-market trading is Amgen Inc. (NASDAQ: AMGN) after the company released its positive data on its osteoporosis treatment that Wall Street was awaiting. This stock is surging to new 52-week highs and getting out from under a very large shadow since it has had almost nothing but problems since 2006. [...]]]></description>
			<content:encoded><![CDATA[<p>The most active stock in pre-market trading is Amgen Inc. (NASDAQ: AMGN) after the company released its<a href="http://www.biohealthinvestor.com/2008/07/amgen-gets-the-gorilla-off-its-neck-amgn.html"> positive data on its osteoporosis treatment</a> that Wall Street was awaiting.</p>
<p>This stock is surging to new 52-week highs and getting out from under a very large shadow since it has had almost nothing but problems since 2006.</p>
<p>Amgen has seen more than 4.7 million shares trade hands (9:04 AM) today with shares up at $61.60.  Its prior 52-week high was $59.08.  After this news was released late Friday after the close, we saw shares trade over 2.66 million after the close and the last after-hours print Friday was $61.60.</p>
<p>It&#8217;s probably a safe bet that with Amgen posting earnings today and with a such a gap up top 52-week highs we&#8217;ll be expecting Amgen stock options to be among the most active.</p>
<p>Jon Ogg<br />
July 28, 2008</p>
]]></content:encoded>
			<wfw:commentRss>http://vsinvestor.com/2008/07/52-week-highvolume-surge-amgen-amgn.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

